Clinical Trial Update: A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 study investigated the effects of GSK561679 on brain activation during emotional processing in healthy volunteers. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorder
• Depressive Disorder

Drugs mentioned

• GSK561679 (GSK561679)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder and Anxiety Disorders | Phase 1 | Status: COMPLETED